Paper41002483
Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer.
Iurciuc Tincu CE and 11 others. Gels, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer. Papers, record 41002483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41002483
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of an Innovative Nanosystem Based on Functionalized Albumin and Oxidized Gellan for the Synergistic Delivery of Curcumin and Temozolomide in the Treatment of Brain Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References119
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28747713 | Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433). | Sci Rep | 2017 | https://conductscience.org/library/papers/28747713 | PubMed |
| 2 | 26037706 | Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity. | Colloids Surf B Biointerfaces | 2015 | https://conductscience.org/library/papers/26037706 | PubMed |
| 3 | 28280335 | Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1). | Int J Nanomedicine | 2017 | https://conductscience.org/library/papers/28280335 | PubMed |
| 4 | 36839945 | The Effect of Curcumin-Loaded Glucan Nanoparticles on Immune Cells: Size as a Critical Quality Attribute. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839945 | PubMed |
| 5 | 25148603 | Albumin hydrogels formed by electrostatically triggered self-assembly and their drug delivery capability. | Biomacromolecules | 2014 | https://conductscience.org/library/papers/25148603 | PubMed |
| 6 | 28150932 | Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers. | ACS Appl Mater Interfaces | 2017 | https://conductscience.org/library/papers/28150932 | PubMed |
| 7 | 25356469 | 1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987. | J Control Release | 2014 | https://conductscience.org/library/papers/25356469 | PubMed |
| 8 | 29329242 | Absorption and Metabolism of Phenolics from Digests of Polyphenol-Rich Potato Extracts Using the Caco-2/HepG2 Co-Culture System. | Foods | 2018 | https://conductscience.org/library/papers/29329242 | PubMed |
| 9 | 17371541 | Potential functional role of plasmacytoid dendritic cells in cancer immunity. | Immunology | 2007 | https://conductscience.org/library/papers/17371541 | PubMed |
| 10 | 27299311 | Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. | Pharm Res | 2016 | https://conductscience.org/library/papers/27299311 | PubMed |
| 11 | 39005962 | Albumin Nanoparticle-Based Drug Delivery Systems. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/39005962 | PubMed |
| 12 | 25003794 | Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. | J Control Release | 2014 | https://conductscience.org/library/papers/25003794 | PubMed |
| 13 | 31540426 | Aptamer-Functionalized Liposomes as a Potential Treatment for Basal Cell Carcinoma. | Polymers (Basel) | 2019 | https://conductscience.org/library/papers/31540426 | PubMed |
| 14 | 35209225 | Thermodynamic Solubility Profile of Temozolomide in Different Commonly Used Pharmaceutical Solvents. | Molecules | 2022 | https://conductscience.org/library/papers/35209225 | PubMed |
| 15 | 31261723 | In Silico Prediction of PAMPA Effective Permeability Using a Two-QSAR Approach. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31261723 | PubMed |
| 16 | 10869357 | Substrate specificity in the highly heterogeneous M4 peptidase family is determined by a small subset of amino acids. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10869357 | PubMed |
| 17 | 22029860 | Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image. | Biomacromolecules | 2012 | https://conductscience.org/library/papers/22029860 | PubMed |
| 18 | 9278892 | Stability of curcumin in buffer solutions and characterization of its degradation products. | J Pharm Biomed Anal | 1997 | https://conductscience.org/library/papers/9278892 | PubMed |
| 19 | 30176744 | Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. | Drug Deliv | 2018 | https://conductscience.org/library/papers/30176744 | PubMed |
| 20 | 29670967 | Investigation of HSA as a biocompatible coating material for arsenic trioxide nanoparticles. | Nanoscale | 2018 | https://conductscience.org/library/papers/29670967 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| FPR1 | 2357 | PubTator's text mining | https://conductscience.org/library/genes/2357 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41002483
GET https://conductscience.org/api/papers/v1/41002483/references?page=2